Lenacapavir is a new HIV prevention drug offered as a twice-yearly injection, available for about $40 annually in 120 low- and middle-income countries starting in 2027. This initiative arises from a partnership including Gilead Sciences and several Indian generic manufacturers. While this move could significantly reduce new HIV infections, especially in high-burden countries, concerns remain about access for middle-income nations that are excluded from these deals.
Campaigners emphasize that these countries often face collapsing healthcare systems and need urgent assistance. Additionally, funding is critical not only for producing the drug but also for awareness, training healthcare workers, and logistics.
Gilead aims to deliver lenacapavir to the countries most affected by HIV, but transparency around pricing and access, especially for excluded regions, is still needed. Advocates are urging comprehensive strategies to ensure that all communities benefit from this breakthrough in medicine.
Difficult words
- drug — A substance used for medical treatment.
- access — The opportunity to use something.
- campaigners — People who support a cause or change.
- assist — To help someone or something.assistance
- reduce — To make something smaller or less.
- transparency — Openness about actions and decisions.
- strategy — A plan to achieve a goal.strategies
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- What are your thoughts on the importance of drug accessibility?
- How can awareness about new drugs be improved?
- What challenges do you think middle-income countries will face?
Related articles
Patch Could Help Repair Heart After Attack
A new patch may help the heart heal after an attack by delivering healing molecules directly to the damaged area.
Twenty Minutes Twice a Week May Slow Dementia
A new study led by Texas A&M researchers found that 20 minutes of exercise twice weekly may help slow dementia progression in older adults. The team used 2012–2020 Health and Retirement Study data and noted some study limits.
AI and Citizens Spot Invasive Mosquito in Madagascar
Researchers have used AI and citizen photos to identify a dangerous mosquito in Madagascar, showing how communities can help monitor this threat.
Communities at Risk Receive Support for Communication
An online service connects communities at risk and helps them communicate about their challenges. It offers advice and support for effective risk communication.
Higgs Boson Scientists Address Air Pollution in South Africa
A new AI system helps monitor air quality in South Africa, aiming to tackle pollution issues effectively.
New Malaria Drug Shows Promise Against Resistance
A new malaria treatment called GanLum could help overcome drug resistance. It works differently from existing medications, making it effective against resistant parasites.